NewGenIvf Group Limited (NASDAQ:NIVF) Sees Large Decrease in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 89,521 shares, a decrease of 54.0% from the May 31st total of 194,483 shares. Approximately 1.3% of the company’s stock are sold short. Based on an average daily volume of 2,421,281 shares, the short-interest ratio is currently 0.0 days.

NewGenIvf Group Stock Up 3.3%

Shares of NASDAQ:NIVF traded up $0.02 during midday trading on Tuesday, reaching $0.54. The company had a trading volume of 586,863 shares, compared to its average volume of 3,038,136. The company’s 50 day moving average price is $1.07 and its 200 day moving average price is $3.65. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. NewGenIvf Group has a 52-week low of $0.47 and a 52-week high of $372.00.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million for the quarter. On average, equities analysts expect that NewGenIvf Group will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Insider Buying and Selling at NewGenIvf Group

In other news, major shareholder Financial Lp Hrt purchased 137,541 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average cost of $0.99 per share, for a total transaction of $136,165.59. Following the completion of the acquisition, the insider owned 111,885 shares in the company, valued at $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 31.80% of the stock is owned by insiders.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.